Market Closed -
NSE India S.E.
07:43:47 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1,045
INR
|
+3.80%
|
|
+18.82%
|
+15.07%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
10,896
|
14,427
|
5,620
|
10,571
|
17,235
|
10,007
|
Enterprise Value (EV)
1 |
10,833
|
13,684
|
5,502
|
10,009
|
16,538
|
8,604
|
P/E ratio
|
14.7
x
|
9.4
x
|
5.85
x
|
14.9
x
|
10.7
x
|
12.5
x
|
Yield
|
1.44%
|
1.63%
|
2.24%
|
1.34%
|
1.64%
|
1.41%
|
Capitalization / Revenue
|
1.82
x
|
1.75
x
|
0.8
x
|
1.41
x
|
1.46
x
|
0.92
x
|
EV / Revenue
|
1.81
x
|
1.66
x
|
0.78
x
|
1.34
x
|
1.4
x
|
0.79
x
|
EV / EBITDA
|
8.71
x
|
5.43
x
|
4.22
x
|
8.18
x
|
7.16
x
|
6.58
x
|
EV / FCF
|
21.6
x
|
19.2
x
|
13.4
x
|
23.3
x
|
-173
x
|
10.4
x
|
FCF Yield
|
4.64%
|
5.21%
|
7.46%
|
4.28%
|
-0.58%
|
9.64%
|
Price to Book
|
2.05
x
|
2.06
x
|
0.8
x
|
1.24
x
|
1.5
x
|
0.81
x
|
Nbr of stocks (in thousands)
|
12,571
|
12,571
|
12,571
|
12,571
|
12,571
|
12,571
|
Reference price
2 |
866.8
|
1,148
|
447.0
|
841.0
|
1,371
|
796.0
|
Announcement Date
|
7/17/18
|
7/17/19
|
9/1/20
|
8/30/21
|
8/30/22
|
8/22/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,988
|
8,250
|
7,031
|
7,495
|
11,780
|
10,898
|
EBITDA
1 |
1,244
|
2,518
|
1,303
|
1,223
|
2,309
|
1,307
|
EBIT
1 |
1,095
|
2,339
|
1,083
|
961
|
2,011
|
1,003
|
Operating Margin
|
18.3%
|
28.36%
|
15.41%
|
12.82%
|
17.07%
|
9.2%
|
Earnings before Tax (EBT)
1 |
1,069
|
2,342
|
1,149
|
1,008
|
2,135
|
1,058
|
Net income
1 |
738.9
|
1,535
|
960.7
|
710.9
|
1,612
|
799.4
|
Net margin
|
12.34%
|
18.6%
|
13.66%
|
9.48%
|
13.68%
|
7.33%
|
EPS
2 |
58.78
|
122.1
|
76.43
|
56.55
|
128.2
|
63.59
|
Free Cash Flow
1 |
502.4
|
713.6
|
410.7
|
428.7
|
-95.65
|
829.1
|
FCF margin
|
8.39%
|
8.65%
|
5.84%
|
5.72%
|
-0.81%
|
7.61%
|
FCF Conversion (EBITDA)
|
40.37%
|
28.34%
|
31.51%
|
35.04%
|
-
|
63.41%
|
FCF Conversion (Net income)
|
67.99%
|
46.5%
|
42.74%
|
60.3%
|
-
|
103.72%
|
Dividend per Share
2 |
12.50
|
18.75
|
10.00
|
11.25
|
22.50
|
11.25
|
Announcement Date
|
7/17/18
|
7/17/19
|
9/1/20
|
8/30/21
|
8/30/22
|
8/22/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
62.4
|
743
|
118
|
563
|
697
|
1,403
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
502
|
714
|
411
|
429
|
-95.7
|
829
|
ROE (net income / shareholders' equity)
|
15.7%
|
24.9%
|
13.7%
|
9.16%
|
16.1%
|
6.69%
|
ROA (Net income/ Total Assets)
|
10.2%
|
17.8%
|
7.31%
|
5.86%
|
9.68%
|
4.21%
|
Assets
1 |
7,270
|
8,627
|
13,147
|
12,122
|
16,659
|
18,997
|
Book Value Per Share
2 |
424.0
|
557.0
|
558.0
|
677.0
|
914.0
|
988.0
|
Cash Flow per Share
2 |
3.210
|
2.860
|
16.60
|
33.70
|
24.10
|
2.840
|
Capex
1 |
520
|
462
|
652
|
477
|
737
|
325
|
Capex / Sales
|
8.68%
|
5.6%
|
9.28%
|
6.36%
|
6.26%
|
2.98%
|
Announcement Date
|
7/17/18
|
7/17/19
|
9/1/20
|
8/30/21
|
8/30/22
|
8/22/23
|
|
1st Jan change
|
Capi.
|
---|
| +1.19% | 3.58B | | -17.77% | 2.21B | | -13.26% | 1.85B | | -0.69% | 1.8B | | -5.70% | 1.6B | | -2.11% | 1.27B | | -2.91% | 1.1B | | -22.97% | 1.02B | | -8.05% | 951M |
Pesticide
|